Open Access

[Corrigendum] CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway

  • Authors:
    • Junpeng Ji
    • Tianyu Shen
    • Yang Li
    • Yixi Liu
    • Zhiqun Shang
    • Yuanjie Niu
  • View Affiliations

  • Published online on: July 17, 2023     https://doi.org/10.3892/or.2023.8602
  • Article Number: 165
  • Copyright : © Ji et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Oncol Rep 45: [Related article:] 921–932, 2021; DOI: 10.3892/or.2021.7920

Subsequently to the publication of the above paper, an interested reader drew to the authors' attention that a pair of the data panels showing the results of Transwell invasion assays (specifically, the ‘C4-2 / shCON’ and the PC-3 / CON panels) featured in Fig. 3F on p. 927 contained overlapping sections, such that data that were intended to show the results from differently performed experiments appeared to have been derived from the same original source.

The authors were able to re-examine their original data files, and realized that this figure had been inadverently assembled incorrectly. The revised version of Fig. 3, containing the correct representative image of the PC-3shCON group, is shown on the next page. The authors also noted that the statistics in Fig. 3G remained correct, and did not require correction on account of the error made in assembling this figure. Similarly, note that the correction made to this figure does not affect the overall conclusions reported in the paper. The authors are grateful to the Editor of Oncology Reports for allowing them the opportunity to publish this Corrigendum, and all the authors agree with its publication. They also apologize to the readership for any inconvenience caused.

Related Articles

Journal Cover

September-2023
Volume 50 Issue 3

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Ji J, Shen T, Li Y, Liu Y, Shang Z and Niu Y: [Corrigendum] CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway. Oncol Rep 50: 165, 2023
APA
Ji, J., Shen, T., Li, Y., Liu, Y., Shang, Z., & Niu, Y. (2023). [Corrigendum] CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway. Oncology Reports, 50, 165. https://doi.org/10.3892/or.2023.8602
MLA
Ji, J., Shen, T., Li, Y., Liu, Y., Shang, Z., Niu, Y."[Corrigendum] CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway". Oncology Reports 50.3 (2023): 165.
Chicago
Ji, J., Shen, T., Li, Y., Liu, Y., Shang, Z., Niu, Y."[Corrigendum] CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway". Oncology Reports 50, no. 3 (2023): 165. https://doi.org/10.3892/or.2023.8602